Testing effectiveness (Phase 2)Looking for participantsNCT07188103
What this trial is testing
Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma
Who this might be right for
Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital 37